Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
Vereecken
P
P
Monsieur
E
E
Petein
M
M
Heenen
M
M
D000279:Administration, Cutaneous; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001478:Basal Cell Nevus Syndrome; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D005145:Face; D006801:Humans; D000077271:Imiquimod; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod